NCT07087340 (UBLoop-Gen) is a NA clinical trial of UBLoop System in Type-1-Diabetes, sponsored by University of Bern.

Who is sponsoring NCT07087340?

NCT07087340 is sponsored by University of Bern.

What drugs are being tested in NCT07087340?

Interventions in NCT07087340: UBLoop System.

What condition does NCT07087340 study?

NCT07087340 studies Type-1-Diabetes.

Is NCT07087340 still recruiting?

NCT07087340 is currently recruiting now. Last updated 13 February 2026.

Last reviewed 2026-02-13 · How we verify

NCT07087340: UBLoop-Gen

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis

Recruiting now NA Last updated 13 February 2026

What this trial tests

NA trial testing UBLoop System in Type-1-Diabetes in 6 participants. Currently enrolling.

Timeline

21 January 2026

Primary endpoint
30 April 2026

30 April 2026

Quick facts

Lead sponsor	University of Bern
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	6
Start date	21 January 2026
Primary completion	30 April 2026
Estimated completion	30 April 2026
Sites	1 location across Switzerland

Drugs / interventions tested

UBLoop System

Conditions studied

Type-1-Diabetes — all drugs for Type-1-Diabetes →

Sponsor

University of Bern

Who can join

Adults 18 to 65, any sex, with Type-1-Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is investigating the early feasibility of a novel algorithm for a hybrid closed-loop (HCL) insulin delivery system in adult patients with Type 1 diabetes. Participants will attend a study visit where the UBLoop system on a smartphone will manage insulin delivery via an insulin pump, using blood glucose values from a continuous glucose meter. Specialized staff and a remote monitoring system, which is integrated into the UBLoop system, will oversee the participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Bern trials

Trials by the same sponsor.

NCT05940662 — Cost Effectiveness of Various Implant Placement Protocols in the Esthetic Zone · Phase 4 · suspended
NCT02919163 — Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 6 of 7) · NA · not yet recruiting
NCT02919189 — Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 5 of 7) · NA · not yet recruiting
NCT04817592 — Characterization of the Corneal Biomechanics of Patients Treated by Corneal Lenticule Extraction for Advanced Refractive · not yet recruiting
NCT06806150 — The INSPIRE Study: INvestigation of Swiss Physicians Inner-life, Resilience, and Emotions · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07087340 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Bern
Last refreshed: 13 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07087340.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing